Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biliary tract carcinomas: from chemotherapy to targeted therapy.
Marino D, Leone F, Cavalloni G, Cagnazzo C, Aglietta M. Marino D, et al. Crit Rev Oncol Hematol. 2013 Feb;85(2):136-48. doi: 10.1016/j.critrevonc.2012.06.006. Epub 2012 Jul 17. Crit Rev Oncol Hematol. 2013. PMID: 22809696 Review.
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).
Leone F, Marino D, Cereda S, Filippi R, Belli C, Spadi R, Nasti G, Montano M, Amatu A, Aprile G, Cagnazzo C, Fasola G, Siena S, Ciuffreda L, Reni M, Aglietta M. Leone F, et al. Among authors: marino d. Cancer. 2016 Feb 15;122(4):574-81. doi: 10.1002/cncr.29778. Epub 2015 Nov 5. Cancer. 2016. PMID: 26540314 Free article. Clinical Trial.
Fluoropyrimidine-induced cardiotoxicity.
Depetris I, Marino D, Bonzano A, Cagnazzo C, Filippi R, Aglietta M, Leone F. Depetris I, et al. Among authors: marino d. Crit Rev Oncol Hematol. 2018 Apr;124:1-10. doi: 10.1016/j.critrevonc.2018.02.002. Epub 2018 Feb 7. Crit Rev Oncol Hematol. 2018. PMID: 29548480 Review.
"Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer.
Lombardi P, Silvestri S, Marino D, Santarelli M, Campra D, De Paolis P, Aglietta M, Leone F; Rete Oncologica Piemonte e Valle d’Aosta. Lombardi P, et al. Among authors: marino d. Crit Rev Oncol Hematol. 2019 Jan;133:17-24. doi: 10.1016/j.critrevonc.2018.10.009. Epub 2018 Nov 2. Crit Rev Oncol Hematol. 2019. PMID: 30661653 Review.
Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
Leone F, Artale S, Marino D, Cagnazzo C, Cascinu S, Pinto C, Fornarini G, Tampellini M, Di Fabio F, Sartore-Bianchi A, De Carlis L, Pugliese R, Capussotti L, Gioeni L, Siena S, Aglietta M. Leone F, et al. Among authors: marino d. Cancer. 2013 Oct 1;119(19):3429-35. doi: 10.1002/cncr.28223. Epub 2013 Jul 18. Cancer. 2013. PMID: 23868516 Free article. Clinical Trial.
Corrigendum to ""Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer" [Crit. Rev. Oncol. Hematol. 133 (January) (2019) 17-24].
Lombardi P, Silvestri S, Marino D, Santarelli M, Campra D, De Paolis P, Aglietta M, Leone F; Rete Oncologica Piemonte e Valle d’Aosta. Lombardi P, et al. Among authors: marino d. Crit Rev Oncol Hematol. 2020 Apr;148:102867. doi: 10.1016/j.critrevonc.2020.102867. Epub 2020 Feb 12. Crit Rev Oncol Hematol. 2020. PMID: 32062312 No abstract available.
552 results